The Numbers Behind the GLP-1 Manufacturing Race: What the Capacity Data Actually Shows
Every headline about GLP-1 drugs leads with sales or supply shortages. Few look past those headlines to the capacity numbers underneath. That is where the real story sits. Reactor timelines, lead times, and site locations shape supply far more than any sales figure. These
